Treat to Target in Rheumatic Diseases: Rationale and Results (Volume 45-4) (The Clinics: Internal Medicine, Volume 45-4) - Hardcover

 
9780323678964: Treat to Target in Rheumatic Diseases: Rationale and Results (Volume 45-4) (The Clinics: Internal Medicine, Volume 45-4)
Hardcover
ISBN 10: 0323678963 ISBN 13: 9780323678964
Verlag: Elsevier, 2019

Inhaltsangabe

Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover “Treat to Target in Rheumatic Diseases” with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Daniel Aletaha is a consultant rheumatologist at the Medical University of Vienna and a renowned scientist in outcomes research, clinical trials, and translational research in rheumatoid arthritis and other inflammatory rheumatic diseases. He received academic degrees from the Medical University in Vienna, Duke University in North Carolina, and Danube University Krems. Daniel has spent more than two years at the National Institutes of Health in Bethesda, Maryland. Daniel Aletaha is a highly cited author of the field of rheumatology and author of more than 200 publications. He is also associate editor of Arthritis and Rheumatology and RMD Open, and editorial board member of a number of rheumatology specialty journals.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag
Elsevier
Erscheinungsdatum
2019
Sprache
Englisch
ISBN 10 
0323678963
ISBN 13 
9780323678964
Einband
Gebundene Ausgabe
Herausgeber
Aletaha Daniel
Kontakt zum Hersteller
ELSEVIER
https://www.elsevier.com/es-es

Mooswaldallee 6
Freiburg
79108
Deutschland